Abstract: This invention is directed to a composition comprising one or more human immunodeficiency virus type 2 (HIV-2) envelope proteins and a pharmaceutically acceptable carrier. The proteins of the claimed invention are gp300, p200 and p90/80 of HIV-2. The composition is useful for the diagnostic assay of HIV-2 and as an antigen for the production of antibodies, for example.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
May 2, 2000
Assignee:
Institut Pasteur and Centre Nationale de la Recherche Scientifique (C.N.R.S.)
Inventors:
Luc Montagnier, Anne G. Laurent-Crawford, Bernard Krust, Ara G. Hovanessian, Marie-Anne Rey Cuille